Omeros | OMER - 負債





負債 変化する 日付
Adma Biologics USD 83.12M 702K 2025-09
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
BioMarin Pharmaceutical USD 1.44B 833.74M 2026-03
Cytokinetics USD 1.29B 4.48M 2026-03
Gilead Sciences USD 24.94B 5M 2025-12
Heron Therapeutics USD 149.65M 157K 2024-09
Immunic USD 0 0 2024-06
Insmed USD 727.62M 275K 2026-03
Knight Therapeutics CAD 77.91M 28.33M 2025-12
MacroGenics USD 37.01M 238K 2025-09
Omeros USD 442.16M 199K 2023-09
Pacira USD 367.66M 4.53M 2026-03
Pfizer USD 63.73B 231M 2026-03
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.04B 210.44M 2025-12
United Therapeutics USD 200M 100M 2025-03
Vertex Pharmaceuticals USD 1.99B 44M 2026-03
Xoma USD 120.79M 3.27M 2024-06